Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide Maintenance in DLBCL
NCT03016000Phase 3Unknown
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Jul 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of thalidomide in diffuse large B-cell lymphoma (DLBCL), sponsored by Nanfang Hospital, Southern Medical University. Status: unknown.
02
Drugs
thalidomide
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT03016000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03016000.